Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 3/2023

20.07.2022 | Original Paper

Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk

verfasst von: Dan Zhang, Lihua Xu, Yuou Xie, Xiaochen Tang, Yegang Hu, Xu Liu, Guisen Wu, Zhenying Qian, Yingying Tang, Zhi Liu, Tao Chen, HaiChun Liu, Tianhong Zhang, Jijun Wang

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Eye movement abnormalities have been established as an “endophenotype” of schizophrenia. However, less is known about the possibility of these abnormalities as biomarkers for psychosis conversion among clinical high risk (CHR) populations. In the present study, 108 CHR individuals and 70 healthy controls (HC) underwent clinical assessments and eye-tracking tests, comprising fixation stability and free-viewing tasks. According to three-year follow-up outcomes, CHR participants were further stratified into CHR-converter (CHR-C; n = 21) and CHR-nonconverter (CHR-NC; n = 87) subgroups. Prediction models were constructed using Cox regression and logistic regression. The CHR-C group showed more saccades of the fixation stability test (no distractor) and a reduced saccade amplitude of the free-viewing test than HC. Moreover, the CHR-NC group exhibited excessive saccades and an increased saccade amplitude of the fixation stability test (no distractor; with distractor) compared with HC. Furthermore, two indices could effectively discriminate CHR-C from CHR-NC with an area under the receiver-operating characteristic (ROC) curve of 0.80, including the saccade number of the fixation stability test (no distractor) and the saccade amplitude of the free-viewing test. Combined with negative symptom scores of the Scale of Prodromal Symptoms, the area was 0.81. These findings support that eye movement alterations might emerge before the onset of clinically overt psychosis and could assist in predicting psychosis transition among CHR populations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R (2015) Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry 77:147–157. https://doi.org/10.1016/j.biopsych.2014.05.023CrossRefPubMed Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R (2015) Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry 77:147–157. https://​doi.​org/​10.​1016/​j.​biopsych.​2014.​05.​023CrossRefPubMed
8.
Zurück zum Zitat Cui H, Giuliano AJ, Zhang T, Xu L, Wei Y, Tang Y, Qian Z, Stone LM, Li H, Whitfield-Gabrieli S, Niznikiewicz M, Keshavan MS, Shenton ME, Wang J, Stone WS (2020) Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the shanghai-at-risk-for-psychosis (sharp) study: associations with clinical outcomes. Schizophr Res 226:138–146. https://doi.org/10.1016/j.schres.2020.06.018CrossRefPubMed Cui H, Giuliano AJ, Zhang T, Xu L, Wei Y, Tang Y, Qian Z, Stone LM, Li H, Whitfield-Gabrieli S, Niznikiewicz M, Keshavan MS, Shenton ME, Wang J, Stone WS (2020) Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the shanghai-at-risk-for-psychosis (sharp) study: associations with clinical outcomes. Schizophr Res 226:138–146. https://​doi.​org/​10.​1016/​j.​schres.​2020.​06.​018CrossRefPubMed
17.
Zurück zum Zitat Kleineidam L, Frommann I, Ruhrmann S, Klosterkötter J, Brockhaus-Dumke A, Wölwer W, Gaebel W, Maier W, Wagner M, Ettinger U (2019) Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion. Eur Arch Psychiatry Clin Neurosci 269:921–930. https://doi.org/10.1007/s00406-018-0973-4CrossRefPubMed Kleineidam L, Frommann I, Ruhrmann S, Klosterkötter J, Brockhaus-Dumke A, Wölwer W, Gaebel W, Maier W, Wagner M, Ettinger U (2019) Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion. Eur Arch Psychiatry Clin Neurosci 269:921–930. https://​doi.​org/​10.​1007/​s00406-018-0973-4CrossRefPubMed
23.
Zurück zum Zitat McGlashan T, Walsh B, Woods S (2010) The psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford University Press, New York McGlashan T, Walsh B, Woods S (2010) The psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford University Press, New York
24.
31.
Zurück zum Zitat Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW (2020) Polygenic risk score contribution to psychosis prediction in a target population of persons at clinical high risk. Am J Psychiatry 177:155–163. https://doi.org/10.1176/appi.ajp.2019.18060721CrossRefPubMed Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW (2020) Polygenic risk score contribution to psychosis prediction in a target population of persons at clinical high risk. Am J Psychiatry 177:155–163. https://​doi.​org/​10.​1176/​appi.​ajp.​2019.​18060721CrossRefPubMed
35.
Zurück zum Zitat Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-international neuropsychiatric interview (m.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for dsm-iv and icd-10. J Clin Psychiatry 59(Suppl 20):22–33 (quiz 34-57)PubMed Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-international neuropsychiatric interview (m.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for dsm-iv and icd-10. J Clin Psychiatry 59(Suppl 20):22–33 (quiz 34-57)PubMed
38.
Zurück zum Zitat Tang Y, Wang J, Zhang T, Xu L, Qian Z, Cui H, Tang X, Li H, Whitfield-Gabrieli S, Shenton ME, Seidman LJ, McCarley RW, Keshavan MS, Stone WS, Wang J, Niznikiewicz MA (2020) P300 as an index of transition to psychosis and of remission: data from a clinical high risk for psychosis study and review of literature. Schizophr Res 226:74–83. https://doi.org/10.1016/j.schres.2019.02.014CrossRefPubMed Tang Y, Wang J, Zhang T, Xu L, Qian Z, Cui H, Tang X, Li H, Whitfield-Gabrieli S, Shenton ME, Seidman LJ, McCarley RW, Keshavan MS, Stone WS, Wang J, Niznikiewicz MA (2020) P300 as an index of transition to psychosis and of remission: data from a clinical high risk for psychosis study and review of literature. Schizophr Res 226:74–83. https://​doi.​org/​10.​1016/​j.​schres.​2019.​02.​014CrossRefPubMed
42.
Zurück zum Zitat Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T (2019) Real-world effectiveness and safety of antipsychotics in individuals at clinical high-risk for psychosis: study protocol for a prospective observational study (shanghai at risk for psychosis-phase 2). Neuropsychiatr Dis Treat 15:3541–3548. https://doi.org/10.2147/ndt.S230904CrossRefPubMedPubMedCentral Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T (2019) Real-world effectiveness and safety of antipsychotics in individuals at clinical high-risk for psychosis: study protocol for a prospective observational study (shanghai at risk for psychosis-phase 2). Neuropsychiatr Dis Treat 15:3541–3548. https://​doi.​org/​10.​2147/​ndt.​S230904CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Zhang TH, Li HJ, Woodberry KA, Xu LH, Tang YY, Guo Q, Cui HR, Liu XH, Chow A, Li CB, Jiang KD, Xiao ZP, Seidman LJ, Wang JJ (2017) Two-year follow-up of a chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. Epidemiol Psychiatr Sci 26:287–298. https://doi.org/10.1017/s2045796016000184CrossRefPubMed Zhang TH, Li HJ, Woodberry KA, Xu LH, Tang YY, Guo Q, Cui HR, Liu XH, Chow A, Li CB, Jiang KD, Xiao ZP, Seidman LJ, Wang JJ (2017) Two-year follow-up of a chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. Epidemiol Psychiatr Sci 26:287–298. https://​doi.​org/​10.​1017/​s204579601600018​4CrossRefPubMed
Metadaten
Titel
Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk
verfasst von
Dan Zhang
Lihua Xu
Yuou Xie
Xiaochen Tang
Yegang Hu
Xu Liu
Guisen Wu
Zhenying Qian
Yingying Tang
Zhi Liu
Tao Chen
HaiChun Liu
Tianhong Zhang
Jijun Wang
Publikationsdatum
20.07.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 3/2023
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-022-01463-z

Weitere Artikel der Ausgabe 3/2023

European Archives of Psychiatry and Clinical Neuroscience 3/2023 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.